Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MicroPort CardioFlow
AddedFeb 15, 2024
UpdatedJun 28, 2026
MicroPort CardioFlow

MicroPort CardioFlow

Public

MicroPort CardioFlow, a global leader in minimally invasive therapies for structural heart diseases, innovating for quality life.

HQ
Shanghai, Shanghai, CN
Founded
2015
Overview
Compare
Fundraising
Employees

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services.

We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.

MicroPort CardioFlow - Similar Companies

MicroPort Scientific logo

MicroPort Scientific

Cardio Flow logo

Cardio Flow

cardioflow.net

Micro Interventional Devices logo

Micro Interventional Devices

Edwards Lifesciences logo

Edwards Lifesciences

edwards.com

4C Medical Technologies logo

4C Medical Technologies

4cmed.com

MicroPort Orthopedics logo

MicroPort Orthopedics

microportortho.com

TriFlo Cardiovascular logo

TriFlo Cardiovascular

triflocv.com

Cardiac Dimensions logo

Cardiac Dimensions

CardioFocus logo

CardioFocus

cardiofocus.com

Capstan Medical logo

Capstan Medical

capstanmedical.com

Polynova Cardiovascular logo

Polynova Cardiovascular

Moray Medical logo

Moray Medical

moraymedical.com

Boston Scientific logo

Boston Scientific

Heartflow logo

Heartflow

Tau-Pnu Medical logo

Tau-Pnu Medical

MicroPort CardioFlow - Quick Facts

Who are MicroPort CardioFlow's competitors?

Companies similar to MicroPort CardioFlow include MicroPort Scientific, Cardio Flow, Micro Interventional Devices and Edwards Lifesciences.

When was MicroPort CardioFlow founded?

MicroPort CardioFlow was founded in 2015.

Where is MicroPort CardioFlow's headquarters located?

MicroPort CardioFlow's headquarters is located in Shanghai, Shanghai, CN.

When was MicroPort CardioFlow's last funding round?

MicroPort CardioFlow's most recent funding round was for $130M (USD) in April 2020.

How much has MicroPort CardioFlow raised to-date?

As of Apr 21, 2020, MicroPort CardioFlow has raised a total of $130M (USD).

How many employees does MicroPort CardioFlow have?

MicroPort CardioFlow has 750 employees as of Feb 4, 2024.

MicroPort CardioFlow - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified